Stay updated on Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing v3.4.1, which is a minor update with no changes to study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T15:55:01.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The recruitment/status changed to Completed. The study completion date (Actual) is listed as 2026-01-09, with updates through 2026-01-30 and a new revision (v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-05T11:27:11.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated page metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed/changed older labels such as 'Last Update Submitted that met QC Criteria' (capitalization), 'No FEAR Act data', and the older 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-29T03:22:32.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed on the page, replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:39:40.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section listing Maryland as a study site. Removed the HHS Vulnerability Disclosure link and the older Maryland Locations entry.
    Difference
    0.2%
    Check dated 2025-12-23T17:15:21.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2. This change does not modify the study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2025-11-24T20:59:50.000Z thumbnail image

Stay in the know with updates to Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial page.